Phase II Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Vascularization of Liver Metastases of Metastatic Colorectal Cancer: Proof of Concept Study

Trial Profile

Phase II Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Vascularization of Liver Metastases of Metastatic Colorectal Cancer: Proof of Concept Study

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Anakinra (Primary) ; Bevacizumab; Cisplatin; Fluorouracil; Folinic acid
  • Indications Colorectal cancer
  • Focus Proof of concept; Therapeutic Use
  • Acronyms IRAFU
  • Most Recent Events

    • 19 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 23 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Oct 2016 as per ClinicalTrials.gov record.
    • 01 Oct 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top